Celon Laboratories
About Celon Laboratories
Celon Laboratories is a Healthcare company based in Hyderabad (India) founded in 2007 by Ravindra K V and Vimal Kavuru, and was acquired by Development Partners International in November 2020. Oncology and critical care pharmaceuticals are manufactured and marketed. Celon Laboratories has raised $61.41 million across 7 funding rounds from investors including European Union, British International Investment and Eight Roads Ventures. The company has 535 employees. Celon Laboratories was last valued at $54.48 million in June 2016. Its chief executive, as recorded, is Ravindra K V. Its Indian entity Celon Laboratories Private Limited reported revenue of ₹148 Cr. Celon Laboratories offers products and services including Oncology Products and Critical Care Products. Its focus areas include Traditional Pharmaceuticals, Generics, Therapeutic Areas and Oncology.
Company details
Celon Laboratories was established in 2007 in Hyderabad, India, focusing on the pharmaceutical sector. Products in oncology, anti-infective, and critical care areas are developed, manufactured, and marketed, including tablets, capsules, ampoules, vials, pre-filled syringes, and emulsion injections. Contract research and manufacturing services are offered, encompassing formulation development, lyophilization, quality control testing, stability studies, and regulatory support. Markets served include the Asia Pacific, Africa, Latin America, CIS countries, and Eastern Europe.
- Headquarters Hyderabad, India
- Employees 535
- Founders Ravindra K V, Vimal Kavuru
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website celonlabs.com
- Social LinkedIn X Facebook YouTube
- Acquired by Development Partners International (Nov 2020)
- Legal Name Celon Laboratories Private Limited
- Date of Incorporation 23 Jan, 2001
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹148 Cr
FY 2025 · -7% YoY
- Net Loss-₹43.73 Cr
FY 2025 · -30% margin
- EBITDA-₹20.55 Cr
FY 2025 · -14% margin
- Total Equity Funding$61.41M (USD)
in 7 rounds
- Latest Funding Round$25.66M (USD), Series B
Jun 2016
- InvestorsEuropean Union
& 13 more
- Employee Count535
- Acquired byDevelopment Partners International
(Nov 2020)
Associated legal entities of Celon Laboratories
Celon Laboratories operates through Celon Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Celon Laboratories Private Limited CIN U24232TG2001PTC036097 | Active | 23 Jan 2001 | Hyderabad, Telangana | ₹148 Cr | 535 | 3 | View details |
Products & Services of Celon Laboratories
Celon Laboratories offers a comprehensive portfolio of products and services, including Oncology Products and Critical Care Products.
Formulations for cancer treatment are developed and marketed in niche areas.
Products for cardiovascular and anesthesia segments are provided to support patient care.
Apps and channels of Celon Laboratories
its YouTube channel Celon Labs has 110 subscribers.
Funding Insights of Celon Laboratories
Celon Laboratories has successfully raised a total of $61.41M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $25.66 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61.41M
- Total Rounds 7
- Last Round Series B — $25.66M
- First Round $15.81M
(Oct 2010)
- Investors Count 11
All 7 funding rounds of Celon Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | $25.66M | Series B | $54.48M | My Home Labs | |
| Sep 2015 | $11M | Series B | – | – | |
| May 2014 | $3.19M | Series A | $26.45M | Sequoia Capital | |
| Feb 2014 | $322,888 | Angel Round | $••••• | Ramaswamy Chowdhary Gummadi | – |
| Dec 2013 | $1.03M | Series A | $••••• | Sequoia Capital | |
| Sep 2011 | $4.4M | Series A | $••••• | Sequoia Capital | |
| Oct 2010 | $15.81M | Series A | $••••• | – |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2016 | $54.48M | •••••••• |
| May 2014 | $26.45M | •••••••• |
| Feb 2014 | $••••• | •••••••• |
| Dec 2013 | $••••• | •••••••• |
| Sep 2011 | $••••• | •••••••• |
| Oct 2010 | $••••• | •••••••• |
Full valuation and stage history of Celon Laboratories
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $54.48M (Jun 2016). 14 investors in total: 6 institutional and 8 angel.
Investors in Celon Laboratories
Celon Laboratories has secured backing from 14 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include European Union, British International Investment and Eight Roads Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
Venture capital investment and global platform support for startups. | 2008 | eightroads.com | London, United Kingdom | |
Government agency focused on small and medium-sized businesses | 1948 | bii.co.uk | London, United Kingdom | |
A premier African investment firm focused on high-growth businesses. | 2007 | dpi-llp.com | London, United Kingdom | |
| myhomelabs.tcc.mode | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
SK Sudha Kavuru | unknown_f57590f6401943908 | |||
VK Vimal Kavuru | Angel investor, entrepreneur, focused on tech startups, based in India. | unknown_9bef4601ff4e4b15b | ||
VK Vijay Kumar Vasireddy | Angel investor, tech entrepreneur, and mentor in Indian startup ecosystem | unknown_be8598ec25b84ebe8 | ||
RC Ramaswamy Chowdhary Gummadi | unknown_d8735bce7f3145f49 |
Investor details for Celon Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Celon Laboratories Private Limited (Celon Laboratories)
Celon Laboratories Private Limited is the primary company behind Celon Laboratories. The board of Celon Laboratories Private Limited currently have 2 directors; the longest-serving is Ajay Bhatia, appointed in 2024. 29 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ajay Bhatia DIN 08074866 | Managing Director | 02 May 2024 | 2 yrs 5 mo | Celon Laboratories Private Limited |
| Ravi Kumar Upputhalla DIN 08852313 | Company Secretary | 02 Apr 2025 | 1 yr 6 mo | Celon Laboratories Private Limited |
People of Celon Laboratories
6 people are tracked at Celon Laboratories (3 in leadership, 2 in board & advisors, 1 in team); the tracked headcount is 535.
| Name | Role | Group |
|---|---|---|
Ravindra K V | Co-Founder, CEO & Managing Director | Leadership |
Vimal Kavuru | Co-Founder | Leadership |
| Managing Director | Leadership | |
Hocine Sidi-Said | Chairman | Board & advisors |
Irfan Ahmed | Director | Board & advisors |
Mukesh Sharma | Sales Manager:hospital Business: North And East Zone: Corporate & Govt|critical Care|anaesthesia| | Team |
Complete people profiles for Celon Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Celon Laboratories
Figures of Celon Laboratories Private Limited, the primary company behind Celon Laboratories, for FY 2025. Revenue was ₹148 Cr (-7% year on year). Net loss was -₹43.73 Cr (-30% margin). EBITDA was -₹20.55 Cr (-14% margin). Revenue has grown at a compounded annual rate of -31% over three years and -6% over five years.
- ₹148 CrRevenue · FY 2025 · -7% YoY
- -₹43.73 CrNet loss · -30% margin
- -₹20.55 CrEBITDA · -14% margin
- ₹65.10 CrPaid-up capital
- 535Employees (provident fund records)
- -31%Revenue CAGR, 3 years
- -6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Celon Laboratories Private Limited are on its company page.
Detailed financial statements for Celon Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Celon Laboratories
5 dated milestones of Celon Laboratories across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Celon Laboratories is founded.
- Funding First funding round of $15.8M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series B, of $25.7M.
- Exit Acquired by Development Partners International.
Web traffic of Celon Laboratories
The website of Celon Laboratories (celonlabs.com) receives about 1.2K visits a month and ranks #10,181,864 among all websites worldwide, #7,857 in Biotechnology and Pharmaceuticals.
- Monthly visits1.2K
▼ 32.2% vs previous month
- Global rank#10,181,864
among all websites
- Category rank#7,857
Health · Biotechnology and Pharmaceuticals
- Bounce rate34%
- Pages per visit1.2
- Average visit1 min 51 sec
- DevicesDesktop 44% · Mobile 56%
Websites whose visitors overlap most with Celon Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| celonpharma.com | 100% | 14K | #2,315,042 | View details | |
cortechslabs.com | cortechslabs.com | 61% | – |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Celon Laboratories (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Celon Laboratories
Complete news archive for Celon Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celon Laboratories
Celon Laboratories was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Celon Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Ravindra K V is the CEO of Celon Laboratories, as recorded in our data. They have also founded this company.
Celon Laboratories is a funded company, having raised a total of $61.41M across 7 funding rounds to date. The company's 1st funding round was a Series A of $15.81M, raised on Oct 2010.
Celon Laboratories has 535 employees.
The primary company behind Celon Laboratories, Celon Laboratories Private Limited, reported revenue of ₹148 Cr for FY 2025, down 7% year on year.
Celon Laboratories was established in 2007 in Hyderabad, India, focusing on the pharmaceutical sector. Products in oncology, anti-infective, and critical care areas are developed, manufactured, and marketed, including tablets, capsules, ampoules, vials, pre-filled syringes, and emulsion injections. Contract research and manufacturing services are offered, encompassing formulation development, lyophilization, quality control testing, stability studies, and regulatory support. Markets served include the Asia Pacific, Africa, Latin America, CIS countries, and Eastern Europe.
Celon Laboratories offers Oncology Products and Critical Care Products.
Celon Laboratories has 14 investors. Key investors include European Union, British International Investment, Eight Roads Ventures, My Home Labs, and Sequoia Capital.
The valuation of Celon Laboratories is $54.48M as of Jun 2016.
Celon Laboratories operates through Celon Laboratories Private Limited.
Yes. Celon Laboratories was acquired by Development Partners International in November 2020.